Status:
TERMINATED
Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
Lead Sponsor:
Rasim Gucalp
Collaborating Sponsors:
Millennium Pharmaceuticals, Inc.
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to develop new treatments that will hopefully result in the relief of symptoms and prolongation of life. For this reason, your doctors have offered you treatment with a ne...
Eligibility Criteria
Inclusion
- Patients must have confirmed NSCLC (squamous, adeno- and large cell anaplastic carcinoma)stage III B or Stage IV.
- No prior chemotherapy regimen Patients must have adequate organ and marrow function
Exclusion
- Untreated symptomatic brain metastasis Patients with known HIV positivity
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00200382
Start Date
May 1 2004
End Date
May 1 2007
Last Update
August 2 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
HealthAlliance Hospitals
Fitchburg, Massachusetts, United States, 01420
2
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
3
Albert Einstein Cancer Center
The Bronx, New York, United States, 10461
4
Jacobi Medical Center
The Bronx, New York, United States, 10461